Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825 Article

Strauss, Joshua D, Gilbert, Mark R, Mehta, Minesh et al. (2024). Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825 . Neuro-Oncology, 27(3), 767-778. 10.1093/neuonc/noae234

Open Access

cited authors

  • Strauss, Joshua D; Gilbert, Mark R; Mehta, Minesh; Li, Ang; Zhou, Renke; Bondy, Melissa L; Sulman, Erik P; Yuan, Ying; Liu, Yanhong; Vera, Elizabeth; Wendland, Merideth M; Stieber, Volker W; Puduvalli, Vinay K; Choi, Serah; Martinez, Nina L; Robins, H Ian; Hunter, Grant K; Lin, Chi-Fan; Guedes, Vivian A; Richard, Melissa A; Pugh, Stephanie L; Armstrong, Terri S; Scheurer, Michael E

sustainable development goals

authors

publication date

  • December 3, 2024

published in

keywords

  • BEVACIZUMAB-INDUCED HYPERTENSION
  • CANCER
  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • PREDICTIVE MARKER
  • SURVIVAL
  • Science & Technology
  • VALIDATION
  • bevacizumab
  • genome-wide association study
  • glioblastoma
  • hypertension
  • thrombosis

Digital Object Identifier (DOI)

start page

  • 767

end page

  • 778

volume

  • 27

issue

  • 3